ReviewInternational journal of molecular sciences2025
Recent Advances in the Synthesis and Biological Applications of Prenylated Chalcones.
Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Role of Natural Chalcones and Their Derivatives in Targeting Prostate Cancer: Recent Updates.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Prenylated chalcones, a subclass of chalcones distinguished by the addition of one or more prenyl (3-methylbut-2-enyl) groups, have attracted significant attention due to their promising biological activities. The origins, chemical diversity, and synthetic routes used to prepare naturally occurring and synthetic prenylated chalcones are discussed in this review paper, alongside their diverse pharmacological properties, as reported over the past 10 years (2015-2025), mainly emphasising their strong anti-cancer, anti-inflammatory, anti-bacterial, anti-fungal, anti-parasitic, and anti-malarial effects. We address their structure-activity relationships (SARs) to interrogate how prenylation affects the pharmacological activity of these chalcones.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.